These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24841259)

  • 1. Radicicol confers mid-schizont arrest by inhibiting mitochondrial replication in Plasmodium falciparum.
    Chalapareddy S; Bhattacharyya MK; Mishra S; Bhattacharyya S
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4341-52. PubMed ID: 24841259
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Singh P; Tabassum W; Fangaria N; Dey S; Padhi S; Bhattacharyya MK; Arun Kumar K; Roy A; Bhattacharyya S
    Microbiol Spectr; 2023 Jun; 11(3):e0498022. PubMed ID: 37212694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular docking and molecular dynamics simulation identify a novel Radicicol derivative that predicts exclusive binding to
    Bansod S; Raj N; R A; Nair AS; Bhattacharyya S
    J Biomol Struct Dyn; 2022 Sep; 40(15):6939-6951. PubMed ID: 33650468
    [No Abstract]   [Full Text] [Related]  

  • 4. Antimalarial effect of N-acetyl-L-Leucyl-L-leucyl-L-norleucinal by the inhibition of Plasmodium falciparum Calpain.
    Jung SY; Zheng B; Choi YY; Soh BY; Kim SY; Park KI; Park H
    Arch Pharm Res; 2009 Jun; 32(6):899-906. PubMed ID: 19557368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue.
    Sonoiki E; Ng CL; Lee MC; Guo D; Zhang YK; Zhou Y; Alley MR; Ahyong V; Sanz LM; Lafuente-Monasterio MJ; Dong C; Schupp PG; Gut J; Legac J; Cooper RA; Gamo FJ; DeRisi J; Freund YR; Fidock DA; Rosenthal PJ
    Nat Commun; 2017 Mar; 8():14574. PubMed ID: 28262680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraerythrocytic expression of topoisomerase II from Plasmodium falciparum is developmentally regulated.
    Cheesman S; Horrocks P; Tosh K; Kilbey B
    Mol Biochem Parasitol; 1998 Apr; 92(1):39-46. PubMed ID: 9574908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplasmodial activity and mechanism of action of RSM-932A, a promising synergistic inhibitor of Plasmodium falciparum choline kinase.
    Zimmerman T; Moneriz C; Diez A; Bautista JM; Gómez Del Pulgar T; Cebrián A; Lacal JC
    Antimicrob Agents Chemother; 2013 Dec; 57(12):5878-88. PubMed ID: 24041883
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Sharma S; Kaitholia K; Mishra N; Srivastava B; Pillai CR; Valecha N; Anvikar AR
    Indian J Med Microbiol; 2016; 34(4):509-512. PubMed ID: 27934832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium falciparum Choline Kinase Inhibition Leads to a Major Decrease in Phosphatidylethanolamine Causing Parasite Death.
    Serrán-Aguilera L; Denton H; Rubio-Ruiz B; López-Gutiérrez B; Entrena A; Izquierdo L; Smith TK; Conejo-García A; Hurtado-Guerrero R
    Sci Rep; 2016 Sep; 6():33189. PubMed ID: 27616047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radicicol-Mediated Inhibition of Topoisomerase VIB-VIA Activity of the Human Malaria Parasite Plasmodium falciparum.
    Chalapareddy S; Chakrabarty S; Bhattacharyya MK; Bhattacharyya S
    mSphere; 2016; 1(1):. PubMed ID: 27303712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the timing of action of antimalarial drugs against Plasmodium falciparum.
    Wilson DW; Langer C; Goodman CD; McFadden GI; Beeson JG
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1455-67. PubMed ID: 23318799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Plasmodium falciparum proliferation in vitro by double-stranded RNA nanoparticle against malaria topoisomerase II.
    Attasart P; Boonma S; Sunintaboon P; Tanwilai D; Pothikasikorn J; Noonpakdee WT
    Exp Parasitol; 2016 May; 164():84-90. PubMed ID: 26953249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-Cell Phenotypic Screening of Medicines for Malaria Venture Pathogen Box Identifies Specific Inhibitors of
    Patra AT; Hingamire T; Belekar MA; Xiong A; Subramanian G; Bozdech Z; Preiser P; Shanmugam D; Chandramohanadas R
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo properties of ellagic acid in malaria treatment.
    Soh PN; Witkowski B; Olagnier D; Nicolau ML; Garcia-Alvarez MC; Berry A; Benoit-Vical F
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1100-6. PubMed ID: 19015354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptidic boronic acids are potent cell-permeable inhibitors of the malaria parasite egress serine protease SUB1.
    Lidumniece E; Withers-Martinez C; Hackett F; Collins CR; Perrin AJ; Koussis K; Bisson C; Blackman MJ; Jirgensons A
    Proc Natl Acad Sci U S A; 2021 May; 118(20):. PubMed ID: 33975947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The
    Henrici RC; Edwards RL; Zoltner M; van Schalkwyk DA; Hart MN; Mohring F; Moon RW; Nofal SD; Patel A; Flueck C; Baker DA; Odom John AR; Field MC; Sutherland CJ
    mBio; 2020 Feb; 11(1):. PubMed ID: 32098816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A patatin-like phospholipase is important for mitochondrial function in malaria parasites.
    Pietsch E; Ramaprasad A; Bielfeld S; Wohlfarter Y; Maco B; Niedermüller K; Wilcke L; Kloehn J; Keller MA; Soldati-Favre D; Blackman MJ; Gilberger T-W; Burda P-C
    mBio; 2023 Dec; 14(6):e0171823. PubMed ID: 37882543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yeast-based high-throughput screen identifies Plasmodium falciparum equilibrative nucleoside transporter 1 inhibitors that kill malaria parasites.
    Frame IJ; Deniskin R; Rinderspacher A; Katz F; Deng SX; Moir RD; Adjalley SH; Coburn-Flynn O; Fidock DA; Willis IM; Landry DW; Akabas MH
    ACS Chem Biol; 2015 Mar; 10(3):775-83. PubMed ID: 25602169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial type II NADH dehydrogenase of Plasmodium falciparum (PfNDH2) is dispensable in the asexual blood stages.
    Ke H; Ganesan SM; Dass S; Morrisey JM; Pou S; Nilsen A; Riscoe MK; Mather MW; Vaidya AB
    PLoS One; 2019; 14(4):e0214023. PubMed ID: 30964863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (-)-Epigallocatechin-3-Gallate Inhibits the Chaperone Activity of Plasmodium falciparum Hsp70 Chaperones and Abrogates Their Association with Functional Partners.
    Zininga T; Ramatsui L; Makhado PB; Makumire S; Achilinou I; Hoppe H; Dirr H; Shonhai A
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29206141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.